Symbols / CMPS
CMPS Chart
About
COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. The company was incorporated in 2020 and is headquartered in London, the United Kingdom.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Medical Care Facilities | Market Cap | 778.73M |
| Enterprise Value | 507.92M | Income | -237.32M | Sales | — |
| Book/sh | 0.39 | Cash/sh | 1.94 | Dividend Yield | — |
| Payout | 0.00% | Employees | 166 | IPO | — |
| P/E | — | Forward P/E | -5.97 | PEG | — |
| P/S | — | P/B | 17.50 | P/C | — |
| EV/EBITDA | -3.29 | EV/Sales | — | Quick Ratio | 1.15 |
| Current Ratio | 1.23 | Debt/Eq | 93.60 | LT Debt/Eq | — |
| EPS (ttm) | -2.72 | EPS next Y | -1.15 | EPS Growth | — |
| Revenue Growth | — | Earnings | 2026-03-12 | ROA | -38.43% |
| ROE | -205.81% | ROIC | — | Gross Margin | 0.00% |
| Oper. Margin | 0.00% | Profit Margin | 0.00% | Shs Outstand | 113.52M |
| Shs Float | 73.40M | Short Float | 5.80% | Short Ratio | 4.29 |
| Short Interest | — | 52W High | 8.90 | 52W Low | 2.25 |
| Beta | 1.98 | Avg Volume | 2.63M | Volume | 3.44M |
| Target Price | $21.92 | Recom | Strong_buy | Prev Close | $6.58 |
| Price | $6.86 | Change | 4.26% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$21.92
Mean price target
2. Current target
$6.86
Latest analyst target
3. DCF / Fair value
$7.51
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$6.86
Low
$8.00
High
$70.00
Mean
$21.92
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-03-02 | main | HC Wainwright & Co. | Buy → Buy | $70 |
| 2026-02-18 | main | Canaccord Genuity | Buy → Buy | $20 |
| 2026-02-18 | main | Morgan Stanley | Overweight → Overweight | $18 |
| 2026-02-18 | main | RBC Capital | Outperform → Outperform | $22 |
| 2026-01-23 | main | RBC Capital | Outperform → Outperform | $21 |
| 2025-11-05 | main | Morgan Stanley | Overweight → Overweight | $11 |
| 2025-10-13 | main | BTIG | Buy → Buy | $14 |
| 2025-08-04 | main | HC Wainwright & Co. | Buy → Buy | $40 |
| 2025-08-01 | main | Canaccord Genuity | Buy → Buy | $15 |
| 2025-07-15 | reit | HC Wainwright & Co. | Buy → Buy | $45 |
| 2025-06-23 | down | Evercore ISI Group | Outperform → In-Line | $6 |
| 2025-05-12 | reit | HC Wainwright & Co. | Buy → Buy | $45 |
| 2025-03-28 | reit | Cantor Fitzgerald | Overweight → Overweight | — |
| 2025-03-04 | reit | HC Wainwright & Co. | Buy → Buy | $45 |
| 2025-02-28 | main | Canaccord Genuity | Buy → Buy | $15 |
| 2025-02-27 | init | Stifel | — → Buy | $11 |
| 2025-02-13 | main | HC Wainwright & Co. | Buy → Buy | $45 |
| 2025-01-15 | reit | RBC Capital | Outperform → Outperform | $18 |
| 2024-11-01 | main | HC Wainwright & Co. | Buy → Buy | $60 |
| 2024-11-01 | main | Maxim Group | Buy → Buy | $12 |
- Psychedelic pill eases hard-to-treat depression in big Compass trial - Stock Titan ue, 17 Feb 2026 08
- COMPASS Pathways plc (NASDAQ:CMPS) has caught the attention of institutional investors who hold a sizeable 32% stake - Yahoo Finance Sat, 11 Oct 2025 07
- COMPASS Pathways plc - Depositary Receipt (CMPS) Price Target Increased by 12.63% to 19.84 - Nasdaq Wed, 25 Feb 2026 21
- CMPS Stock Slumps Premarket As $150M Offering Cuts Into Psychedelic Trial Buzz - Stocktwits Wed, 18 Feb 2026 09
- COMPASS Pathways (CMPS) Stock Analysis: Unveiling a Potential 164.89% Upside in the Psychedelic Therapy Space - DirectorsTalk Interviews Sat, 28 Feb 2026 02
- Why COMPASS Pathways (CMPS) Is Up 21.3% After Phase 3 Psilocybin Win And $150M Equity Raise - simplywall.st Wed, 18 Feb 2026 08
- Analysts Bullish on COMPASS Pathways plc (CMPS) Following Psychedelics Symposium and Model Updates - Finviz Wed, 18 Feb 2026 08
- Compass Pathways Announces Pricing of $150 Million Public Offering - Business Wire Wed, 18 Feb 2026 08
- Compass Pathways jumps on positive Phase 3 COMP006 data for COMP360 in treatment-resistant depression - Quiver Quantitative ue, 17 Feb 2026 08
- Mental health biotech Compass Pathways to webcast TD Cowen fireside chat - Stock Titan ue, 24 Feb 2026 08
- BTIG Maintains COMPASS Pathways plc - Depositary Receipt (CMPS) Buy Recommendation - Nasdaq Mon, 13 Oct 2025 07
- A Look At COMPASS Pathways (CMPS) Valuation After Positive COMP360 Phase 3 Results And FDA Plans - simplywall.st ue, 24 Feb 2026 08
- Compass Pathways Announces Exercise of $200 Million in Outstanding Warrants - Business Wire hu, 26 Feb 2026 11
- Biotech Compass Pathways seeks $150M in new share sale - Stock Titan ue, 17 Feb 2026 08
- Is COMPASS Pathways (NASDAQ:CMPS) Weighed On By Its Debt Load? - simplywall.st Mon, 08 Dec 2025 08
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 25000 | — | — | Stock Award(Grant) at price 0.00 per share. | LOXAM TERI | Chief Financial Officer | — | 2025-03-11 00:00:00 | D |
| 1 | 776565 | 4993313 | — | Sale at price 6.43 per share. | GOLDSMITH GEORGE JAY | Beneficial Owner of more than 10% of a Class of Security | — | 2024-10-24 00:00:00 | D/I |
| 2 | 1553130 | 9986626 | — | Sale at price 6.43 per share. | MALIEVSKAIA EKATERINA | Beneficial Owner of more than 10% of a Class of Security | — | 2024-10-24 00:00:00 | D/I |
| 3 | 2660000 | 16093000 | — | Sale at price 6.05 per share. | ATAI LIFE SCIENCES NV | Beneficial Owner of more than 10% of a Class of Security | — | 2024-09-26 00:00:00 | I |
| 4 | 31207 | 246567 | — | Sale at price 7.89 - 7.91 per share. | GOLDSMITH GEORGE JAY | Beneficial Owner of more than 10% of a Class of Security | — | 2024-05-21 00:00:00 | D/I |
| 5 | 31207 | 246567 | — | Sale at price 7.89 - 7.91 per share. | MALIEVSKAIA EKATERINA | Beneficial Owner of more than 10% of a Class of Security | — | 2024-05-21 00:00:00 | D/I |
| 6 | 56766 | 490432 | — | Sale at price 8.29 - 8.82 per share. | GOLDSMITH GEORGE JAY | Beneficial Owner of more than 10% of a Class of Security | — | 2024-05-03 00:00:00 | D/I |
| 7 | 56766 | 490432 | — | Sale at price 8.29 - 8.82 per share. | MALIEVSKAIA EKATERINA | Beneficial Owner of more than 10% of a Class of Security | — | 2024-05-03 00:00:00 | D/I |
| 8 | 69461 | 597964 | — | Sale at price 8.53 - 8.78 per share. | GOLDSMITH GEORGE JAY | Beneficial Owner of more than 10% of a Class of Security | — | 2024-04-17 00:00:00 | D/I |
| 9 | 69461 | 597964 | — | Sale at price 8.53 - 8.78 per share. | MALIEVSKAIA EKATERINA | Beneficial Owner of more than 10% of a Class of Security | — | 2024-04-17 00:00:00 | D/I |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | -258.00K | 700.34K | 155.99K | 378.10K |
| TaxRateForCalcs | 0.25 | 0.19 | 0.19 | 0.19 |
| NormalizedEBITDA | -147.78M | -118.92M | -91.59M | -73.36M |
| TotalUnusualItems | -1.03M | 3.69M | 821.00K | 1.99M |
| TotalUnusualItemsExcludingGoodwill | -1.03M | 3.69M | 821.00K | 1.99M |
| NetIncomeFromContinuingOperationNetMinorityInterest | -155.12M | -118.46M | -91.50M | -71.74M |
| ReconciledDepreciation | 233.00K | 242.00K | 330.00K | 175.00K |
| EBITDA | -148.82M | -115.24M | -90.77M | -71.37M |
| EBIT | -149.05M | -115.48M | -91.10M | -71.54M |
| NetInterestIncome | 3.79M | 2.42M | 0.00 | 0.00 |
| InterestExpense | 4.48M | 2.20M | 0.00 | 0.00 |
| InterestIncome | 8.27M | 4.62M | ||
| NormalizedIncome | -154.35M | -121.45M | -92.17M | -73.35M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -155.12M | -118.46M | -91.50M | -71.74M |
| TotalExpenses | 157.11M | 124.04M | 95.98M | 73.57M |
| TotalOperatingIncomeAsReported | -178.21M | -136.92M | -110.40M | -83.22M |
| DilutedAverageShares | 67.48M | 67.48M | 42.44M | 40.00M |
| BasicAverageShares | 67.48M | 67.48M | 42.44M | 40.00M |
| DilutedEPS | -2.30 | -2.32 | -2.16 | -1.79 |
| BasicEPS | -2.30 | -2.32 | -2.16 | -1.79 |
| DilutedNIAvailtoComStockholders | -155.12M | -118.46M | -91.50M | -71.74M |
| NetIncomeCommonStockholders | -155.12M | -118.46M | -91.50M | -71.74M |
| NetIncome | -155.12M | -118.46M | -91.50M | -71.74M |
| NetIncomeIncludingNoncontrollingInterests | -155.12M | -118.46M | -91.50M | -71.74M |
| NetIncomeContinuousOperations | -155.12M | -118.46M | -91.50M | -71.74M |
| TaxProvision | 1.59M | 780.00K | 408.00K | 199.00K |
| PretaxIncome | -153.53M | -117.68M | -91.10M | -71.54M |
| OtherIncomeExpense | -209.00K | 3.94M | 4.88M | 2.03M |
| OtherNonOperatingIncomeExpenses | 823.00K | 255.00K | 4.06M | 40.00K |
| GainOnSaleOfSecurity | -1.03M | 3.69M | 821.00K | 1.99M |
| NetNonOperatingInterestIncomeExpense | 3.79M | 2.42M | 0.00 | 0.00 |
| InterestExpenseNonOperating | 4.48M | 2.20M | 0.00 | 0.00 |
| InterestIncomeNonOperating | 8.27M | 4.62M | ||
| OperatingIncome | -157.11M | -124.04M | -95.98M | -73.57M |
| OperatingExpense | 157.11M | 124.04M | 95.98M | 73.57M |
| OtherTaxes | -21.10M | -12.88M | -14.42M | -9.65M |
| ResearchAndDevelopment | 119.04M | 87.52M | 65.05M | 44.03M |
| SellingGeneralAndAdministration | 59.17M | 49.40M | 45.35M | 39.19M |
| GeneralAndAdministrativeExpense | 59.17M | 49.40M | 45.35M | 39.19M |
| OtherGandA | 26.54M | 22.84M | 22.43M | 39.19M |
| SalariesAndWages | 32.63M | 26.56M | 22.93M | 18.07M |
| TotalRevenue | 0.00 | 0.00 | 0.00 | 0.00 |
| OperatingRevenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Line Item | 2023-12-31 | |||
|---|---|---|---|---|
| TreasurySharesNumber | 0.00 | |||
| OrdinarySharesNumber | 68.55M | 61.94M | 42.63M | 42.02M |
| ShareIssued | 68.55M | 61.94M | 42.63M | 42.02M |
| TotalDebt | 32.19M | 33.05M | 1.93M | 3.61M |
| TangibleBookValue | 154.69M | 225.74M | 181.28M | 284.41M |
| InvestedCapital | 184.86M | 254.50M | 181.28M | 284.41M |
| WorkingCapital | 167.28M | 241.69M | 176.06M | 280.19M |
| NetTangibleAssets | 154.69M | 225.74M | 181.28M | 284.41M |
| CapitalLeaseObligations | 2.03M | 4.29M | 1.93M | 3.61M |
| CommonStockEquity | 154.69M | 225.74M | 181.28M | 284.41M |
| TotalCapitalization | 179.35M | 254.50M | 181.28M | 284.41M |
| TotalEquityGrossMinorityInterest | 154.69M | 225.74M | 181.28M | 284.41M |
| StockholdersEquity | 154.69M | 225.74M | 181.28M | 284.41M |
| OtherEquityInterest | 28.00K | 28.00K | ||
| GainsLossesNotAffectingRetainedEarnings | -16.19M | -16.93M | -16.87M | 8.84M |
| OtherEquityAdjustments | -16.19M | -16.93M | -16.87M | 8.84M |
| RetainedEarnings | -534.73M | -379.61M | -261.15M | -169.64M |
| AdditionalPaidInCapital | 704.92M | 621.64M | 458.82M | 444.75M |
| CapitalStock | 702.00K | 635.00K | 440.00K | 435.00K |
| CommonStock | 702.00K | 635.00K | 440.00K | 435.00K |
| TotalLiabilitiesNetMinorityInterest | 58.97M | 50.24M | 16.01M | 16.49M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 24.95M | 30.64M | 418.00K | 1.38M |
| LongTermDebtAndCapitalLeaseObligation | 24.95M | 30.64M | 418.00K | 1.38M |
| LongTermCapitalLeaseObligation | 303.00K | 1.88M | 418.00K | 1.38M |
| LongTermDebt | 24.65M | 28.76M | ||
| CurrentLiabilities | 34.02M | 19.60M | 15.60M | 15.11M |
| OtherCurrentLiabilities | 1.32M | 1.04M | 656.00K | 268.00K |
| CurrentDebtAndCapitalLeaseObligation | 7.24M | 2.41M | 1.51M | 2.23M |
| CurrentCapitalLeaseObligation | 1.73M | 2.41M | 1.51M | 2.23M |
| CurrentDebt | 5.51M | |||
| OtherCurrentBorrowings | 5.51M | |||
| PensionandOtherPostRetirementBenefitPlansCurrent | 7.91M | 7.07M | 5.53M | 5.02M |
| PayablesAndAccruedExpenses | 17.54M | 9.09M | 7.90M | 7.59M |
| CurrentAccruedExpenses | 5.26M | 3.19M | 2.97M | 4.43M |
| Payables | 12.28M | 5.89M | 4.93M | 3.16M |
| TotalTaxPayable | 0.00 | 0.00 | 167.00K | 593.00K |
| IncomeTaxPayable | 0.00 | 0.00 | 0.00 | |
| AccountsPayable | 12.28M | 5.89M | 4.76M | 2.56M |
| TotalAssets | 213.67M | 275.99M | 197.29M | 300.90M |
| TotalNonCurrentAssets | 12.38M | 14.69M | 5.64M | 5.60M |
| OtherNonCurrentAssets | 200.00K | 202.00K | 327.00K | 213.00K |
| NonCurrentPrepaidAssets | 5.74M | 5.96M | 0.00 | |
| NonCurrentDeferredAssets | 3.77M | 3.34M | 2.22M | 766.00K |
| NonCurrentDeferredTaxesAssets | 3.77M | 3.34M | 2.22M | 766.00K |
| InvestmentsAndAdvances | 469.00K | 469.00K | 469.00K | 525.00K |
| OtherInvestments | 469.00K | 469.00K | 469.00K | |
| NetPPE | 2.19M | 4.73M | 2.62M | 4.09M |
| AccumulatedDepreciation | -530.00K | -358.00K | ||
| GrossPPE | 2.19M | 4.73M | 2.62M | 4.45M |
| Leases | 91.00K | 6.00K | ||
| OtherProperties | 2.19M | 4.73M | 2.62M | 4.07M |
| MachineryFurnitureEquipment | 724.00K | 380.00K | ||
| Properties | 0.00 | 0.00 | ||
| CurrentAssets | 201.29M | 261.30M | 191.65M | 295.30M |
| OtherCurrentAssets | 2.19M | 1.90M | 1.04M | 1.37M |
| CurrentDeferredAssets | 0.00 | 840.00K | ||
| RestrictedCash | 389.00K | 440.00K | 175.00K | 104.00K |
| PrepaidAssets | 11.81M | 9.83M | 31.60M | 8.53M |
| Receivables | 21.82M | 28.93M | 15.62M | 11.22M |
| TaxesReceivable | 21.82M | 28.93M | 15.62M | 11.22M |
| CashCashEquivalentsAndShortTermInvestments | 165.08M | 220.20M | 143.21M | 273.24M |
| CashAndCashEquivalents | 165.08M | 220.20M | 143.21M | 273.24M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -119.19M | -97.44M | -106.05M | -68.08M |
| IssuanceOfDebt | 0.00 | 29.59M | 0.00 | 0.00 |
| IssuanceOfCapitalStock | 26.22M | 144.94M | 440.00K | 154.79M |
| CapitalExpenditure | -66.00K | -596.00K | -334.00K | |
| InterestPaidSupplementalData | 3.07M | 1.25M | ||
| IncomeTaxPaidSupplementalData | 1.12M | 2.44M | ||
| EndCashPosition | 165.47M | 220.64M | 143.38M | 273.35M |
| BeginningCashPosition | 220.64M | 143.38M | 273.35M | 190.36M |
| EffectOfExchangeRateChanges | 194.00K | 867.00K | -24.96M | -5.58M |
| ChangesInCash | -55.36M | 76.39M | -105.01M | 88.57M |
| FinancingCashFlow | 63.82M | 173.83M | 1.04M | 156.65M |
| CashFlowFromContinuingFinancingActivities | 63.82M | 173.83M | 1.04M | 156.65M |
| NetOtherFinancingCharges | -239.00K | -1.04M | ||
| ProceedsFromStockOptionExercised | 37.84M | 353.00K | 600.00K | 1.85M |
| NetPreferredStockIssuance | 0.00 | 0.00 | ||
| PreferredStockIssuance | 0.00 | 0.00 | ||
| NetCommonStockIssuance | 26.22M | 144.94M | 440.00K | 154.79M |
| CommonStockIssuance | 26.22M | 144.94M | 440.00K | 154.79M |
| NetIssuancePaymentsOfDebt | 0.00 | 29.59M | 0.00 | 0.00 |
| NetShortTermDebtIssuance | 0.00 | |||
| ShortTermDebtIssuance | 0.00 | |||
| NetLongTermDebtIssuance | 0.00 | 29.59M | 0.00 | 0.00 |
| LongTermDebtIssuance | 0.00 | 29.59M | 0.00 | 0.00 |
| InvestingCashFlow | 0.00 | -64.00K | -596.00K | -334.00K |
| CashFlowFromContinuingInvestingActivities | 0.00 | -64.00K | -596.00K | -334.00K |
| NetInvestmentPurchaseAndSale | 0.00 | 0.00 | ||
| PurchaseOfInvestment | 0.00 | 0.00 | ||
| NetPPEPurchaseAndSale | 0.00 | -64.00K | -596.00K | -334.00K |
| SaleOfPPE | 0.00 | 2.00K | 0.00 | 0.00 |
| PurchaseOfPPE | 0.00 | -66.00K | -596.00K | -334.00K |
| OperatingCashFlow | -119.19M | -97.38M | -105.45M | -67.75M |
| CashFlowFromContinuingOperatingActivities | -119.19M | -97.38M | -105.45M | -67.75M |
| ChangeInWorkingCapital | 11.72M | 3.48M | -30.67M | -6.64M |
| ChangeInOtherWorkingCapital | 686.00K | -1.66M | -1.70M | -877.00K |
| ChangeInOtherCurrentLiabilities | -2.27M | -1.96M | -2.08M | -1.88M |
| ChangeInOtherCurrentAssets | -307.00K | -160.00K | ||
| ChangeInPayablesAndAccruedExpense | 9.95M | 2.49M | 2.18M | 5.26M |
| ChangeInAccruedExpense | 3.36M | 1.62M | -314.00K | 5.43M |
| ChangeInPayable | 6.59M | 864.00K | 2.50M | -163.00K |
| ChangeInAccountPayable | 6.59M | 864.00K | 2.50M | -163.00K |
| ChangeInPrepaidAssets | 3.35M | 4.62M | -29.07M | -9.14M |
| OtherNonCashItems | 3.71M | 2.66M | 2.13M | 1.80M |
| StockBasedCompensation | 19.52M | 17.28M | 13.12M | 8.64M |
| DepreciationAmortizationDepletion | 233.00K | 242.00K | 330.00K | 175.00K |
| DepreciationAndAmortization | 233.00K | 242.00K | 330.00K | 175.00K |
| OperatingGainsLosses | 755.00K | -2.58M | 1.14M | 22.00K |
| NetForeignCurrencyExchangeGainLoss | 755.00K | -2.62M | 1.14M | 22.00K |
| GainLossOnSaleOfPPE | 0.00 | 40.00K | 0.00 | 0.00 |
| NetIncomeFromContinuingOperations | -155.12M | -118.46M | -91.50M | -71.74M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for CMPS
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|